Serum vitamin D metabolites in younger and elderly postmenopausal women
- 23 Downloads
Previous investigations have suggested that a lower-than-normal serum 1,25(OH)2D is found in elderly women with postmenopausal osteoporosis. We examined the fundamental aspects of this theory by investigating serum vitamin D metabolites infour representative samples of Caucasian women. These included 44 early postmenopausal women divided intotwo subgroups: fast bone losers, that is, bone loss>3%/year (n=20), and “physiological” bone loss (n=24); and 28 70-year-old women divided intotwo subgroups: with and without osteoporotic fractures. Serum 1,25(OH)2D concentrations were virtually the same in all groups thus contradicting the previous reports of low 1,25(OH)2D in elderly women. Furthermore, mean 25OHD and 24,25(OH)2D did not differ between the groups. We conclude that 1,25(OH)2D is unlikely to be significant in the development or treatment of a majority of women with postmenopausal osteoporosis.
Key words1,25-dihydroxyvitamin D 24,25-dihydroxyvitamin D 25-Hydroxyvitamin D Postmenopausal osteoporosis
Unable to display preview. Download preview PDF.
- 1.DeLuca HF (1976) Recent advances in our understanding of the vitamin D endocrine system. J Lab Clin Med 87:7–26Google Scholar
- 3.Soerensen OH, Andersen RB, Christensen MS, Friis T, Hjort L, Joergensen FS, Lund B, Melsen F, Mosekilde L (1977) Treatment of senile osteoporosis with 1α-hydroxy vitamin D3. Clin Endocrinol (suppl 7):169–175Google Scholar
- 4.Lindholm TS, Sevastikoglou JA, Lindgren U (1977) Treatment of patients with senile post-menopausal and corticosteriod-induced osteoporosis with 1α-hydroxyvitamin D3 and calcium: short and long-term effects. Clin Endocrinol (suppl 7):183–189Google Scholar
- 7.Orimo H, Shiraki M (1979) Role of calcium regulating hormones in the pathogenesis of senile osteoporosis. Endocrinol Jpn suppl 26:1–6Google Scholar
- 12.Nordin BEC, Peacock M, Crilly RG, Marshall DH (1979) Calcium absorption and plasma 1,25(OH)2D levels in postmenopausal osteoporosis. In: Norman AW, Schaefer K, Herrath DV, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds) Vitamin D: basic research and its clinical application. Walter de Gruyter, Berlin, New York pp 99–106Google Scholar
- 13.Nordin BEC, Peacock M, Crilly RG, Francis RM, Speed R, Barkworth S (1981) Summations of risk factors in osteoporosis. In: DeLuca HM, Frost HM, Jee WSS, Johnston Jr CC, Parfitt AM Osteoporosis: recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 359–367Google Scholar
- 17.Jensen GF, Christiansen C, Boesen J, Hegedüs V, Transbøl I (1982) Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis. Clin Orthop Rel Res 166:75–81Google Scholar
- 21.Rickers H, Balslev I, Foltved H, Rødbro P (1981) Bone mineral content before and after intestinal bypass operation in obese patients. Acta Med Scand 209-203-207Google Scholar
- 26.Jensen GF, Christiansen C, Transbøl I (1982) Treatment of postmenopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxyvitamin D3 and calcium. Clin Endocrinol 16:515–524Google Scholar
- 30.Christiansen C, Rødbro P, Næstoft J, Christensen MS (1981) A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure. Clin Endocrinol 15:237–242Google Scholar
- 31.Arnaud CD, Gallagher JC, Jerpbak CM, Riggs BL (1981) On the role of parathyroid hormone in the osteoporosis of aging. In: DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM (eds) Osteoporosis. Recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 215–225Google Scholar